These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8617410)

  • 21. Dopamine involvement in thermoregulatory responses to heat in rats.
    Canini F; Bourdon L
    Neurosci Lett; 1998 Jan; 241(2-3):91-4. PubMed ID: 9507928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Piribedil-induced anti-hypoxic protection in rats.
    Saligaut C; Moore N; Daoust M; Chretien P; Boismare F
    Aviat Space Environ Med; 1982 Jan; 53(1):35-9. PubMed ID: 7055488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Piribedil could modify dopamine turnover in cochleas under noise stimulation.
    Vicente-Torres MA; Gil-Loyzaga P; Fernández P; Arce A; Esquifino A
    ORL J Otorhinolaryngol Relat Spec; 1993; 55(6):322-4. PubMed ID: 8265115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of a dopaminergic agonist (piribedil) on cerebral blood flow in man.
    Güell A; Géraud G; Jauzac P; Victor G; Arné-Bès MC
    J Cereb Blood Flow Metab; 1982; 2(2):255-7. PubMed ID: 7076737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of a mechanism responsible for potential antidepressant activity of EMD 386088, a 5-HT6 partial agonist in rats.
    Jastrzębska-Więsek M; Siwek A; Partyka A; Antkiewicz-Michaluk L; Michaluk J; Romańska I; Kołaczkowski M; Wesołowska A
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):839-49. PubMed ID: 27106213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine agonists prevent or counteract the suppression of brain stimulation reward by fenfluramine.
    Olds ME
    Pharmacol Biochem Behav; 1995 Jan; 50(1):41-8. PubMed ID: 7700953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The agonist of dopamine receptors piribedil in treatment of Parkinson's disease].
    Pilipovich AA; Golubev VL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):83-90. PubMed ID: 28745677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cesarean plus anoxia at birth induces hyperresponsiveness to locomotor activity by dopamine D2 agonist.
    Juárez I; De La Cruz F; Zamudio S; Flores G
    Synapse; 2005 Dec; 58(4):236-42. PubMed ID: 16206184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opposing effects on the phrenic motor pathway attributed to dopamine-D1 and -D3/D2 receptor activation.
    Lalley PM; Mifflin SW
    Respir Physiol Neurobiol; 2012 Apr; 181(2):183-93. PubMed ID: 22465544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiparkinsonian agent piribedil displays antagonist properties at native, rat, and cloned, human alpha(2)-adrenoceptors: cellular and functional characterization.
    Millan MJ; Cussac D; Milligan G; Carr C; Audinot V; Gobert A; Lejeune F; Rivet JM; Brocco M; Duqueyroix D; Nicolas JP; Boutin JA; Newman-Tancredi A
    J Pharmacol Exp Ther; 2001 Jun; 297(3):876-87. PubMed ID: 11356907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discriminative stimulus properties of D1 and D2 dopamine agonists in rats.
    Kamien JB; Goldberg LI; Woolverton WL
    J Pharmacol Exp Ther; 1987 Sep; 242(3):804-11. PubMed ID: 2958620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of a D1 and a D2 dopamine antagonist on the self-administration of cocaine and piribedil by rhesus monkeys.
    Woolverton WL
    Pharmacol Biochem Behav; 1986 Mar; 24(3):531-5. PubMed ID: 2871561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The dopamine agonist piribedil with L-DOPA improves attentional dysfunction: relevance for Parkinson's disease.
    Turle-Lorenzo N; Maurin B; Puma C; Chezaubernard C; Morain P; Baunez C; Nieoullon A; Amalric M
    J Pharmacol Exp Ther; 2006 Nov; 319(2):914-23. PubMed ID: 16920993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effect of NMDA and AMPA receptor blockade on protein synthesis in the rat infarct borderzone.
    Christensen T; Bruhn T; Frank L; Diemer NH
    Acta Neurol Scand; 1996; 93(2-3):160-7. PubMed ID: 8741137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, double-blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease.
    Montastruc JL; Ziegler M; Rascol O; Malbezin M
    Mov Disord; 1999 Mar; 14(2):336-41. PubMed ID: 10091630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apomorphine and piribedil in rats: biochemical and pharmacologic studies.
    Butterworth RF; Poignant JC; Barbeau A
    Adv Neurol; 1975; 9():307-26. PubMed ID: 1170716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychomotor and cognitive effects of piribedil, a dopamine agonist, in young healthy volunteers.
    Schück S; Bentué-Ferrer D; Kleinermans D; Reymann JM; Polard E; Gandon JM; Allain H
    Fundam Clin Pharmacol; 2002 Feb; 16(1):57-65. PubMed ID: 11903513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Responses of central neurones to piribedil and 2-bromo-alpha-ergocryptine: comparison with dopamine and apomorphine.
    Bioulac B; Fumoux F; Ferron A; Vincent JD
    Eur J Pharmacol; 1978 Sep; 51(1):29-37. PubMed ID: 699972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. D1 Antagonists and D2 Agonists Have Opposite Effects on the Metabolism of Dopamine in the Rat Striatum.
    Avila-Luna A; Prieto-Leyva J; Gálvez-Rosas A; Alfaro-Rodriguez A; Gonzalez-Pina R; Bueno-Nava A
    Neurochem Res; 2015 Jul; 40(7):1431-7. PubMed ID: 25981954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey.
    Boraud T; Bezard E; Bioulac B; Gross CE
    Brain; 2001 Mar; 124(Pt 3):546-57. PubMed ID: 11222455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.